Array
(
[id] => 444
[catid] => 299
[title] => 穴位刺激辅助治疗术后疼痛临床实践指南(2021)
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/444.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:12:39
[updatetime] => 2024-01-11 15:12:39
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2021
[guojia] => 中国中西医结合学会麻醉专业委员会;甘肃省中西医结合学会麻醉专业委员会
[pdf] =>
[tjyjyw] =>
[lyyw] =>
[laiyuan] => 建议穴位刺激的操作由获得执业医师资格的针灸医生、针灸专业的研究生或经过针灸培训的麻醉医生进行,耳穴贴压和穴位按摩也可由经过培训的研究人员和有经验的护理人员进行。(证据等级:中;推荐强度:弱推荐)
[znzldj] => A
[_inputtime] => 1704957159
[_updatetime] => 1704957159
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议穴位刺激的操作由获得执业医师资格的针灸医生、针灸专业的研究生或经过针灸培训的麻醉医生进行,耳穴贴压和穴位按摩也可由经过培训的研究人员和有经验的护理人员进行。(证据等级:中;推荐强度:弱推荐)
证据评价方法:GRADE
指南质量等级:A
年份:2021
国家:中国中西医结合学会麻醉专业委员会;甘肃省中西医结合学会麻醉专业委员会
Array
(
[id] => 445
[catid] => 299
[title] => 穴位刺激辅助治疗术后疼痛临床实践指南(2021)
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/445.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:12:39
[updatetime] => 2024-01-11 15:12:39
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2021
[guojia] => 中国中西医结合学会麻醉专业委员会;甘肃省中西医结合学会麻醉专业委员会
[pdf] =>
[tjyjyw] =>
[lyyw] =>
[laiyuan] => 建议根据不同手术类型、手术部位,依据中医理论选穴原则、神经节段取穴及经验取穴选择穴位。(证据等级:中;推荐强度:弱推荐)
[znzldj] => A
[_inputtime] => 1704957159
[_updatetime] => 1704957159
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议根据不同手术类型、手术部位,依据中医理论选穴原则、神经节段取穴及经验取穴选择穴位。(证据等级:中;推荐强度:弱推荐)
证据评价方法:GRADE
指南质量等级:A
年份:2021
国家:中国中西医结合学会麻醉专业委员会;甘肃省中西医结合学会麻醉专业委员会
Array
(
[id] => 446
[catid] => 299
[title] => 穴位刺激辅助治疗术后疼痛临床实践指南(2021)
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/446.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:12:39
[updatetime] => 2024-01-11 15:12:39
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2021
[guojia] => 中国中西医结合学会麻醉专业委员会;甘肃省中西医结合学会麻醉专业委员会
[pdf] =>
[tjyjyw] =>
[lyyw] =>
[laiyuan] => 穴位刺激适用于所有外科手术术 后疼痛的治疗,但具体穴位刺激方法应根据不同手术类型及部位进行选择。(证据等级:中;推荐强度:弱推荐)
[znzldj] => A
[_inputtime] => 1704957159
[_updatetime] => 1704957159
[_nrjc] =>
[_nrsh] =>
)
推荐意见
穴位刺激适用于所有外科手术术 后疼痛的治疗,但具体穴位刺激方法应根据不同手术类型及部位进行选择。(证据等级:中;推荐强度:弱推荐)
证据评价方法:GRADE
指南质量等级:A
年份:2021
国家:中国中西医结合学会麻醉专业委员会;甘肃省中西医结合学会麻醉专业委员会
Array
(
[id] => 447
[catid] => 243
[title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/447.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:12:39
[updatetime] => 2024-01-11 15:12:39
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://www.jcvaonline.com/article/S1053-0770(19)30296-4/fulltext
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2019
[guojia] => the Network for the Advancement of Patient Blood M
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend against the use of desmopressin for bleeding management in children undergoing cardiac surgery. (1B)
[laiyuan] => 推荐对接受心脏手术的儿童不使用去氨加压素治疗出血。(证据等级:中;推荐强度:强推荐)
[znzldj] => B
[_inputtime] => 1704957159
[_updatetime] => 1704957159
[_nrjc] =>
[_nrsh] =>
)
推荐意见
推荐对接受心脏手术的儿童不使用去氨加压素治疗出血。(证据等级:中;推荐强度:强推荐)
We recommend against the use of desmopressin for bleeding management in children undergoing cardiac surgery. (1B)
证据评价方法:GRADE
指南质量等级:B
年份:2019
国家:the Network for the Advancement of Patient Blood M
Array
(
[id] => 448
[catid] => 243
[title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/448.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:12:39
[updatetime] => 2024-01-11 15:12:39
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2019
[guojia] => the Network for the Advancement of Patient Blood M
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend against the administration of rFVIIa to treat acquired coagulopathy in neonate and children undergoing cardiac surgery. (1C)
[laiyuan] => 推荐不要使用rFVIIa治疗接受心脏手术的新生儿和儿童的获得性凝血病。(证据等级:低;推荐强度:强推荐)
[znzldj] => B
[_inputtime] => 1704957159
[_updatetime] => 1704957159
[_nrjc] =>
[_nrsh] =>
)
推荐意见
推荐不要使用rFVIIa治疗接受心脏手术的新生儿和儿童的获得性凝血病。(证据等级:低;推荐强度:强推荐)
We recommend against the administration of rFVIIa to treat acquired coagulopathy in neonate and children undergoing cardiac surgery. (1C)
证据评价方法:GRADE
指南质量等级:B
年份:2019
国家:the Network for the Advancement of Patient Blood M
Array
(
[id] => 449
[catid] => 243
[title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/449.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:12:39
[updatetime] => 2024-01-11 15:12:39
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2019
[guojia] => the Network for the Advancement of Patient Blood M
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend against the use of PCC in pediatric cardiac surgery unless it is part of a clinical trial. (1C)
[laiyuan] => 建议不要在小儿心脏手术中使用凝血酶原复合物(PCC),除非它是临床试验的一部分。(证据等级:低;推荐强度:强推荐)
[znzldj] => B
[_inputtime] => 1704957159
[_updatetime] => 1704957159
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议不要在小儿心脏手术中使用凝血酶原复合物(PCC),除非它是临床试验的一部分。(证据等级:低;推荐强度:强推荐)
We recommend against the use of PCC in pediatric cardiac surgery unless it is part of a clinical trial. (1C)
证据评价方法:GRADE
指南质量等级:B
年份:2019
国家:the Network for the Advancement of Patient Blood M
Array
(
[id] => 450
[catid] => 243
[title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/450.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:12:39
[updatetime] => 2024-01-11 15:12:39
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2019
[guojia] => the Network for the Advancement of Patient Blood M
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest fresh frozen plasma should ONLY be considered for treating hypofibrinogenemia in bleeding neonates and children when cryoprecipitate or fibrinogen concentrate are not available. (2C)
[laiyuan] => 建议只有在无法获得低温沉淀物或浓缩纤维蛋白原的情况下,才可考虑使用新鲜冰冻血浆治疗出血新生儿和儿童的低纤维蛋白原血症。(证据等级:低;推荐强度:弱推荐)
[znzldj] => B
[_inputtime] => 1704957159
[_updatetime] => 1704957159
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议只有在无法获得低温沉淀物或浓缩纤维蛋白原的情况下,才可考虑使用新鲜冰冻血浆治疗出血新生儿和儿童的低纤维蛋白原血症。(证据等级:低;推荐强度:弱推荐)
We suggest fresh frozen plasma should ONLY be considered for treating hypofibrinogenemia in bleeding neonates and children when cryoprecipitate or fibrinogen concentrate are not available. (2C)
证据评价方法:GRADE
指南质量等级:B
年份:2019
国家:the Network for the Advancement of Patient Blood M
Array
(
[id] => 451
[catid] => 243
[title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/451.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:12:39
[updatetime] => 2024-01-11 15:12:39
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2019
[guojia] => 加拿大、奥地利、英国、比利时
[pdf] =>
[tjyjyw] =>
[lyyw] => For newborns and children diagnosed with hypofibrinogenemia, we recommend treatment with cryoprecipitated or concentrated fibrinogen. (2C)
[laiyuan] => 对于诊断为低纤维蛋白原血症的新生儿和儿童,我们推荐使用低温沉淀或浓缩纤维蛋白原进行治疗。(证据等级:低;推荐强度:弱推荐)
[znzldj] => B
[_inputtime] => 1704957159
[_updatetime] => 1704957159
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于诊断为低纤维蛋白原血症的新生儿和儿童,我们推荐使用低温沉淀或浓缩纤维蛋白原进行治疗。(证据等级:低;推荐强度:弱推荐)
For newborns and children diagnosed with hypofibrinogenemia, we recommend treatment with cryoprecipitated or concentrated fibrinogen. (2C)
证据评价方法:GRADE
指南质量等级:B
年份:2019
国家:加拿大、奥地利、英国、比利时
Array
(
[id] => 452
[catid] => 243
[title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/452.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:12:39
[updatetime] => 2024-01-11 15:12:39
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2019
[guojia] => the Network for the Advancement of Patient Blood M
[pdf] =>
[tjyjyw] =>
[lyyw] => In bleeding neonates and children, we recommend hypofibrinogenemia diagnosed either by Clauss method (< 1.5 g/L) or viscoelastic tests (based on institution-specific algorithm) should be treated. (1C)
[laiyuan] => 对于出血的新生儿和儿童,建议应通过克劳斯法(<1.5g/L)或粘弹性测试(基于特定机构的算法)诊断出低纤维蛋白原血症。。(证据等级:低;推荐强度:强推荐)
[znzldj] => B
[_inputtime] => 1704957159
[_updatetime] => 1704957159
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于出血的新生儿和儿童,建议应通过克劳斯法(<1.5g/L)或粘弹性测试(基于特定机构的算法)诊断出低纤维蛋白原血症。。(证据等级:低;推荐强度:强推荐)
In bleeding neonates and children, we recommend hypofibrinogenemia diagnosed either by Clauss method (< 1.5 g/L) or viscoelastic tests (based on institution-specific algorithm) should be treated. (1C)
证据评价方法:GRADE
指南质量等级:B
年份:2019
国家:the Network for the Advancement of Patient Blood M
Array
(
[id] => 453
[catid] => 243
[title] => Patient Blood Management for Neonates and Children undergoing Cardiac Surgery: 2019 NATA guidelines
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/453.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:12:39
[updatetime] => 2024-01-11 15:12:39
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2019
[guojia] => the Network for the Advancement of Patient Blood M
[pdf] =>
[tjyjyw] =>
[lyyw] => In the presence of excessive bleeding post CPB despite adequate heparin reversal, we suggest platelet transfusion. (2C)
[laiyuan] => 如果在充分逆转肝素后仍出现体外循环后出血过多的情况,建议输注血小板。(证据等级:低;推荐强度:弱推荐)
[znzldj] => B
[_inputtime] => 1704957159
[_updatetime] => 1704957159
[_nrjc] =>
[_nrsh] =>
)
推荐意见
如果在充分逆转肝素后仍出现体外循环后出血过多的情况,建议输注血小板。(证据等级:低;推荐强度:弱推荐)
In the presence of excessive bleeding post CPB despite adequate heparin reversal, we suggest platelet transfusion. (2C)
证据评价方法:GRADE
指南质量等级:B
年份:2019
国家:the Network for the Advancement of Patient Blood M